The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Links

 

Gene Review

PTPRF  -  protein tyrosine phosphatase, receptor...

Homo sapiens

Synonyms: BNAH2, LAR, Leukocyte common antigen related, Receptor-type tyrosine-protein phosphatase F
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of PTPRF

  • Thus PTP-LAR appears to play an important role in the maintenance of epithelial integrity, and a loss of its regulatory function may contribute to malignant progression and metastasis [1].
  • Furthermore, rat mammary carcinomas with elevated neu expression (neu-induced) also had sharply elevated LAR-PTPase expression when compared to rat mammary carcinomas with little or no neu expression (7,12-dimethylbenzanthracene induced); the level of expression of LAR PTPase was directly correlated with the level of neu expression [2].
  • Beta-catenin is tyrosine phosphorylated in three melanoma cell lines and associates with both the ErbB2 receptor tyrosine kinase and the LAR receptor tyrosine phosphatase [3].
  • The cytoplasmic regions of HPTP beta, LCA, and LAR were expressed in Escherichia coli and purified to greater than 90% purity [4].
  • The structure of the human leukocyte-common antigen-related molecule (LAR) protein tyrosine phosphatase gene was elucidated using phage and cosmid genomic DNA clones [5].
 

Psychiatry related information on PTPRF

  • The EAR (0 to 3 hours) and the LAR (3 to 8 hours) were expressed as corresponding areas under the time-response curves [6].
  • CONCLUSION: Negative physical and psychological states were related to low self-efficacy with the taking of immunosuppressive medication, non-compliance and subsequent LAR in our cohort of patients [7].
  • At the present time it is likely that initiation of the inflammatory cascade leading to AFS is a multifactorial event, requiring the simultaneous occurrence of such things as IgE-mediated sensitivity (atopy), specific T-cell HLA receptor expression, exposure to specific fungi, and aberration of local mucosal defense mechanisms [8].
 

High impact information on PTPRF

  • LAR receptor protein tyrosine phosphatases in the development and maintenance of excitatory synapses [9].
  • The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor [10].
  • A human gene (LAR) that hybridizes to mouse leukocyte common antigen cDNA under relaxed hybridization conditions was isolated [11].
  • The LAR gene is expressed in a broad range of cells, including T lymphocytes, kidney, and prostate cells [11].
  • The structure of the protein encoded by the LAR gene was deduced by determining the nucleotide sequences of a 7.7-kb LAR cDNA [11].
 

Chemical compound and disease context of PTPRF

 

Biological context of PTPRF

  • Assignment of TRIO, the Trio gene (PTPRF interacting) to human chromosome bands 5p 15.1-->p 14 by in situ hybridization [17].
  • Our data suggest that increased expression and/or activity of LAR or related PTPs in insulin target tissues of obese humans may contribute to the pathogenesis of insulin resistance [18].
  • Multiple isoforms of LAR, HPTP delta, and HPTP sigma appear to be generated by tissue-specific alternative splicing of up to four mini-exon segments that encode peptides of 4-16 aa located in both the extracellular and intracellular regions [19].
  • Leukocyte common antigen-related (LAR) protein is a widely expressed receptor-type protein-tyrosine-phosphatase that is implicated in the regulation of intracellular signaling triggered by both cell adhesion and peptide growth factors [20].
  • Interestingly, LAR expression significantly decreased the levels of disulfide-linked RET-MEN2A dimerization [20].
 

Anatomical context of PTPRF

  • We propose that LAR and LIP.1 may regulate the disassembly of focal adhesions and thus help orchestrate cell-matrix interactions [21].
  • Interestingly, ectopic expression of protein-tyrosine phosphatase (PTP) LAR inhibits epithelial cell migration by preventing phosphorylation and the increase in the free pool of beta-catenin; moreover, it inhibits tumor formation in nude mice [1].
  • We propose that liprins function to localize LAR family tyrosine phosphatases at specific sites on the plasma membrane, possibly regulating their interaction with the extracellular environment and their association with substrates [22].
  • LAR family transmembrane protein-tyrosine phosphatases function in axon guidance and mammary gland development [22].
  • Liprin-alpha has LAR-independent functions in R7 photoreceptor axon targeting [23].
 

Associations of PTPRF with chemical compounds

  • LAR is a broadly expressed transmembrane protein tyrosine phosphatase comprised of a cell adhesion-like ectodomain and two intracellular protein tyrosine phosphatase domains [21].
  • Taken together, our results suggest that liprin autophosphorylation regulates its association with LAR [24].
  • Endogenous LAR was shown to bind phosphorylated liprin-alpha1 from MDA-486 cells labeled in vivo with [32P]orthophosphate [24].
  • The NH2-terminal region of the extracellular segment of the LAR protein contains three tandem Ig-like domains and nine non-Ig-like domains [11].
  • The functional significance of a stretch of 10 highly conserved amino acid residues surrounding the critical cysteine residue located in the first domain of LAR was assessed [25].
  • In hippocampal neurons, liprinalpha1 mutants that are immune to CaMKII degradation impair dendrite arborization, reduce spine and synapse number, and inhibit dendritic targeting of receptor tyrosine phosphatase LAR, which is important for dendrite development [26].
 

Physical interactions of PTPRF

  • Liprin phosphorylation regulates binding to LAR: evidence for liprin autophosphorylation [24].
  • The laminin-nidogen complex is a ligand for a specific splice isoform of the transmembrane protein tyrosine phosphatase LAR [27].
  • The multidomain protein Trio binds the LAR transmembrane tyrosine phosphatase, contains a protein kinase domain, and has separate rac-specific and rho-specific guanine nucleotide exchange factor domains [28].
 

Enzymatic interactions of PTPRF

  • LAR was phosphorylated by insulin receptor tyrosine kinase and autodephosphorylated by the catalytic activity of the PTPase domain 1 [29].
 

Other interactions of PTPRF

  • The LAR transmembrane protein tyrosine phosphatase and a coiled-coil LAR-interacting protein co-localize at focal adhesions [21].
  • Antibodies against specific IR phosphotyrosines indicated overlapping sites of action of PTP1B and LAR [30].
  • Indirect immunofluorescent antibody staining revealed high expression of LAR in a punctate pattern, throughout the length of these cellular processes observed on laminin-nidogen [27].
  • Rapid and irreversible inactivation of protein tyrosine phosphatases PTP1B, CD45, and LAR by peroxynitrite [31].
  • The bimolecular reaction rates for CD45, LAR, and PTP1B were 2.0 x 10(8), 2.3 x 10(7), and 2.2 x 10(7) M(-1) s(-1), respectively [31].
 

Analytical, diagnostic and therapeutic context of PTPRF

References

  1. Phosphorylation and free pool of beta-catenin are regulated by tyrosine kinases and tyrosine phosphatases during epithelial cell migration. Müller, T., Choidas, A., Reichmann, E., Ullrich, A. J. Biol. Chem. (1999) [Pubmed]
  2. Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene. Zhai, Y.F., Beittenmiller, H., Wang, B., Gould, M.N., Oakley, C., Esselman, W.J., Welsch, C.W. Cancer Res. (1993) [Pubmed]
  3. Geldanamycin abrogates ErbB2 association with proteasome-resistant beta-catenin in melanoma cells, increases beta-catenin-E-cadherin association, and decreases beta-catenin-sensitive transcription. Bonvini, P., An, W.G., Rosolen, A., Nguyen, P., Trepel, J., Garcia de Herreros, A., Dunach, M., Neckers, L.M. Cancer Res. (2001) [Pubmed]
  4. Purification and characterization of the catalytic domains of the human receptor-linked protein tyrosine phosphatases HPTP beta, leukocyte common antigen (LCA), and leukocyte common antigen-related molecule (LAR). Itoh, M., Streuli, M., Krueger, N.X., Saito, H. J. Biol. Chem. (1992) [Pubmed]
  5. Genomic organization of the human LAR protein tyrosine phosphatase gene and alternative splicing in the extracellular fibronectin type-III domains. O'Grady, P., Krueger, N.X., Streuli, M., Saito, H. J. Biol. Chem. (1994) [Pubmed]
  6. The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo. Diamant, Z., Timmers, M.C., van der Veen, H., Friedman, B.S., De Smet, M., Depré, M., Hilliard, D., Bel, E.H., Sterk, P.J. J. Allergy Clin. Immunol. (1995) [Pubmed]
  7. Compliance and late acute rejection after kidney transplantation: a psycho-medical perspective. Baines, L.S., Joseph, J.T., Jindal, R.M. Clinical transplantation. (2002) [Pubmed]
  8. Allergic fungal rhinosinusitis: current theories and management strategies. Marple, B.F. Laryngoscope (2001) [Pubmed]
  9. LAR receptor protein tyrosine phosphatases in the development and maintenance of excitatory synapses. Dunah, A.W., Hueske, E., Wyszynski, M., Hoogenraad, C.C., Jaworski, J., Pak, D.T., Simonetta, A., Liu, G., Sheng, M. Nat. Neurosci. (2005) [Pubmed]
  10. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. Gumperz, J.E., Litwin, V., Phillips, J.H., Lanier, L.L., Parham, P. J. Exp. Med. (1995) [Pubmed]
  11. A new member of the immunoglobulin superfamily that has a cytoplasmic region homologous to the leukocyte common antigen. Streuli, M., Krueger, N.X., Hall, L.R., Schlossman, S.F., Saito, H. J. Exp. Med. (1988) [Pubmed]
  12. Catalytic domains of the LAR and CD45 protein tyrosine phosphatases from Escherichia coli expression systems: purification and characterization for specificity and mechanism. Cho, H., Ramer, S.E., Itoh, M., Kitas, E., Bannwarth, W., Burn, P., Saito, H., Walsh, C.T. Biochemistry (1992) [Pubmed]
  13. Inhibition of the late asthmatic response by nedocromil sodium administered more than two hours after allergen challenge. Pelikan, Z., Knottnerus, I. J. Allergy Clin. Immunol. (1993) [Pubmed]
  14. Co-expression of Mac-1 and p150,95 on CD5+ B cells. Structural and functional characterization in a human chronic lymphocytic leukemia. De la Hera, A., Alvarez-Mon, M., Sanchez-Madrid, F., Martinez, C., Durantez, A. Eur. J. Immunol. (1988) [Pubmed]
  15. Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation. Denu, J.M., Tanner, K.G. Biochemistry (1998) [Pubmed]
  16. Inhibitory effects of formoterol on platelet-activating factor induced eosinophil chemotaxis and degranulation. Eda, R., Sugiyama, H., Hopp, R.J., Okada, C., Bewtra, A.K., Townley, R.G. Int. Arch. Allergy Immunol. (1993) [Pubmed]
  17. Assignment of TRIO, the Trio gene (PTPRF interacting) to human chromosome bands 5p 15.1-->p 14 by in situ hybridization. Taviaux, S., Diriong, S., Bellanger, J.M., Streuli, M., Debant, A. Cytogenet. Cell Genet. (1997) [Pubmed]
  18. Overexpression of the LAR (leukocyte antigen-related) protein-tyrosine phosphatase in muscle causes insulin resistance. Zabolotny, J.M., Kim, Y.B., Peroni, O.D., Kim, J.K., Pani, M.A., Boss, O., Klaman, L.D., Kamatkar, S., Shulman, G.I., Kahn, B.B., Neel, B.G. Proc. Natl. Acad. Sci. U.S.A. (2001) [Pubmed]
  19. The LAR/PTP delta/PTP sigma subfamily of transmembrane protein-tyrosine-phosphatases: multiple human LAR, PTP delta, and PTP sigma isoforms are expressed in a tissue-specific manner and associate with the LAR-interacting protein LIP.1. Pulido, R., Serra-Pagès, C., Tang, M., Streuli, M. Proc. Natl. Acad. Sci. U.S.A. (1995) [Pubmed]
  20. Differential effects of leukocyte common antigen-related protein on biochemical and biological activities of RET-MEN2A and RET-MEN2B mutant proteins. Qiao, S., Iwashita, T., Furukawa, T., Yamamoto, M., Sobue, G., Takahashi, M. J. Biol. Chem. (2001) [Pubmed]
  21. The LAR transmembrane protein tyrosine phosphatase and a coiled-coil LAR-interacting protein co-localize at focal adhesions. Serra-Pagès, C., Kedersha, N.L., Fazikas, L., Medley, Q., Debant, A., Streuli, M. EMBO J. (1995) [Pubmed]
  22. Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-interacting proteins. Serra-Pagès, C., Medley, Q.G., Tang, M., Hart, A., Streuli, M. J. Biol. Chem. (1998) [Pubmed]
  23. Liprin-alpha has LAR-independent functions in R7 photoreceptor axon targeting. Hofmeyer, K., Maurel-Zaffran, C., Sink, H., Treisman, J.E. Proc. Natl. Acad. Sci. U.S.A. (2006) [Pubmed]
  24. Liprin phosphorylation regulates binding to LAR: evidence for liprin autophosphorylation. Serra-Pagès, C., Streuli, M., Medley, Q.G. Biochemistry (2005) [Pubmed]
  25. Distinct functional roles of the two intracellular phosphatase like domains of the receptor-linked protein tyrosine phosphatases LCA and LAR. Streuli, M., Krueger, N.X., Thai, T., Tang, M., Saito, H. EMBO J. (1990) [Pubmed]
  26. Liprinalpha1 degradation by calcium/calmodulin-dependent protein kinase II regulates LAR receptor tyrosine phosphatase distribution and dendrite development. Hoogenraad, C.C., Feliu-Mojer, M.I., Spangler, S.A., Milstein, A.D., Dunah, A.W., Hung, A.Y., Sheng, M. Dev. Cell (2007) [Pubmed]
  27. The laminin-nidogen complex is a ligand for a specific splice isoform of the transmembrane protein tyrosine phosphatase LAR. O'Grady, P., Thai, T.C., Saito, H. J. Cell Biol. (1998) [Pubmed]
  28. The multidomain protein Trio binds the LAR transmembrane tyrosine phosphatase, contains a protein kinase domain, and has separate rac-specific and rho-specific guanine nucleotide exchange factor domains. Debant, A., Serra-Pagès, C., Seipel, K., O'Brien, S., Tang, M., Park, S.H., Streuli, M. Proc. Natl. Acad. Sci. U.S.A. (1996) [Pubmed]
  29. Distinct functions of the two protein tyrosine phosphatase domains of LAR (leukocyte common antigen-related) on tyrosine dephosphorylation of insulin receptor. Tsujikawa, K., Kawakami, N., Uchino, Y., Ichijo, T., Furukawa, T., Saito, H., Yamamoto, H. Mol. Endocrinol. (2001) [Pubmed]
  30. Transgenic overexpression of protein-tyrosine phosphatase 1B in muscle causes insulin resistance, but overexpression with leukocyte antigen-related phosphatase does not additively impair insulin action. Zabolotny, J.M., Haj, F.G., Kim, Y.B., Kim, H.J., Shulman, G.I., Kim, J.K., Neel, B.G., Kahn, B.B. J. Biol. Chem. (2004) [Pubmed]
  31. Rapid and irreversible inactivation of protein tyrosine phosphatases PTP1B, CD45, and LAR by peroxynitrite. Takakura, K., Beckman, J.S., MacMillan-Crow, L.A., Crow, J.P. Arch. Biochem. Biophys. (1999) [Pubmed]
  32. The mouse gene Ptprf encoding the leukocyte common antigen-related molecule LAR: cloning, characterization, and chromosomal localization. Schaapveld, R.Q., van den Maagdenberg, A.M., Schepens, J.T., Weghuis, D.O., Geurts van Kessel, A., Wieringa, B., Hendriks, W.J. Genomics (1995) [Pubmed]
  33. Specific inhibition of FGF-induced MAPK activation by the receptor-like protein tyrosine phosphatase LAR. Wang, X., Weng, L.P., Yu, Q. Oncogene (2000) [Pubmed]
  34. Functional association between the insulin receptor and the transmembrane protein-tyrosine phosphatase LAR in intact cells. Ahmad, F., Goldstein, B.J. J. Biol. Chem. (1997) [Pubmed]
  35. Extinction of insulin-like growth factor-I mitogenic signaling by antiestrogen-stimulated Fas-associated protein tyrosine phosphatase-1 in human breast cancer cells. Freiss, G., Puech, C., Vignon, F. Mol. Endocrinol. (1998) [Pubmed]
  36. Modulation of insulin signal transduction by eutopic overexpression of the receptor-type protein-tyrosine phosphatase LAR. Zhang, W.R., Li, P.M., Oswald, M.A., Goldstein, B.J. Mol. Endocrinol. (1996) [Pubmed]
 
WikiGenes - Universities